Brief: Aker Biomarine Q2 Adjusted EBITDA USD 21 Million, Up 11% y-o-y
July 14 (Reuters) - Aker Biomarine ASA AKBM.OL :
* REVENUES OF USD 73 MILLION AND ADJUSTED EBITDA OF USD 21
MILLION
FOR Q2 2022.
* Q2 REVENUES OF USD 73 MILLION, ON PAR WITH SAME QUARTER
LAST
YEAR
* Q2 ADJUSTED EBITDA OF USD 21 MILLION, UP 11% FROM SAME
QUARTER
LAST YEAR
* ECONREITERATES ITS TARGETS FOR 2022
Source text for Eikon: ID:nObiLgrBja
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker ASA: Conditions For Completion Of Merger With Aker Biomarine Satisfied
Brief: Aker Capital Buys 933,110 Aker BioMarine Shares
Brief: Aker Biomarine To Hold EGM On August 17
Brief: Aker Biomarine: Optional Cash Offer To Shareholders
Brief: Aker Biomarine: Proposed Merger And Optional Cash Offer